Table 4.
Association of glucose and lipid profile levels and other variables at Burayu Health Center, Addis Ababa, Ethiopia, 2012
| Variables |
Glucose/lipid profile levels |
||||
|---|---|---|---|---|---|
|
Gluc >110 mg/dl |
TG ≥ 150 mg/dl |
TC ≥ 200 mg/dl |
HDL < 40 mg/dl |
LDL ≥ 130 mg/dl |
|
| UOR (95% CI) | UOR (95% CI) | UOR (95% CI) | UOR (95% CI) | UOR (95% CI) | |
| Gender (Female) |
0.52(0.19-1.43) |
0.62(0.36-1.10) |
1.18(0.63-2.23) |
1.37(0.77-2.45) |
1.85(0.77-4.42) |
| P-value |
0.208 |
0.097 |
0.608 |
0.289 |
0.167 |
| Age ≥35years |
1.52(0.56-4.12) |
1.23(0.78-2.14) |
2.30(1.29-4.10) |
1.38(0.83-2.30) |
2.57(1.23-5.35) |
| P-value |
0.414 |
0.329 |
0.005 |
0.217 |
0.012 |
| BMI >21.2 |
0.94(0.35-2.53) |
1.27(0.76-2.11) |
2.21(1.24-3.92) |
1.78(1.07-2.98) |
1.78(0.88-3.60) |
| P-value |
0.908 |
0.358 |
0.007 |
0.028 |
0.108 |
| CD4 + cells <200/mm3 |
3.21(1.18-8.73) |
1.59(0.88-2.86) |
0.82(0.42-1.62) |
0.96(0.52-1.75) |
0.57(0.23-1.44) |
| P-value |
0.023 |
0.124 |
0.570 |
0.884 |
0.233 |
| HAART Initiated |
1.47(0.54-3.98) |
1.96(1.17-3.29) |
5.81(3.01-11.2) |
2.62(1.55-4.44) |
3.89(1.76-8.61) |
| P-value |
0.453 |
0.01 |
<0.0001 |
< 0.0001 |
0.001 |
| HIV duration ≥20 months |
1.12(0.42-2.99) |
1.19(0.72-1.98) |
1.98(1.11-3.51) |
1.37(0.82-2.28) |
2.11(1.03-4.35) |
| P-value |
0.828 |
0.500 |
0.020 |
0.231 |
0.042 |
| TB infection |
1.19(0.32-4.33) |
1.11(0.56-2.23) |
0.80(0.36-1.79) |
0.68(0.33-1.42) |
2.28(1.00-5.18) |
| P-value | 0.798 | 0.590 | 0.590 | 0.307 | 0.049 |
HAART, highly active antiretroviral therapy; Gluc, glucose; UOR, un adjusted odds ratio; CI, confidence interval; BMI, body mass index; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglyceride; p, significance level; TB, tuberculosis.